Paul Copeland | Profiles RNS

Paul Copeland, MD

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

General Internal Medicine

MD, Yale University
MPhil, Yale University
MA, Yale University

Websites

	North Shore Medical Center
	Massachusetts General Hospital
	Harvard Catalyst Profile

Dr. Paul Copeland, MD is an endocrinology, diabetes & metabolism specialist in Lynn, MA and has been practicing for 35 years. He graduated from Yale University in 1978 and specializes in endocrinology, diabetes & metabolism and internal medicine.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Wexler DJ, Chang Y, Levy DE, Porneala B, McCarthy J, Rodriguez Romero A, Goldman V, Copeland PM, Steppel-Reznik J, Delahanty LM. Results of a 2-year lifestyle intervention for type 2 diabetes: the Reach Ahead for Lifestyle and Health-Diabetes randomized controlled trial. Obesity (Silver Spring). 2022 Oct; 30(10):1938-1950. PMID: 36046939; PMCID: PMC10949180; DOI: 10.1002/oby.23508;

Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957.View Related Profiles.

Henderson, David
Copeland, Paul

PMID: 30747254

Luo Y, Liu F, Natarajan R, Shukair N, Copeland P, Fan X. Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a pilot study. Int Clin Psychopharmacol. 2018 03; 33(2):88-91. PMID: 29084087; PMCID: PMC5794614; DOI: 10.1097/YIC.0000000000000204;

Nemani KL, Greene MC, Ulloa M, Vincenzi B, Copeland PM, Al-Khadari S, Henderson DC. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. Clin Schizophr Relat Psychoses. 2019; 12(4):168-176.View Related Profiles.

Henderson, David
Copeland, Paul

PMID: 29164928; PMCID: PMC6489443; DOI: 10.3371/CSRP.KNMG.111717;

Henderson DC, Vincenzi B, Andrea NV, Ulloa M, Copeland PM. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015 May; 2(5):452-464.View Related Profiles.

Henderson, David
Copeland, Paul

PMID: 26360288; DOI: 10.1016/S2215-0366(15)00115-7;

Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 25261882; PMCID: PMC4311769; DOI: 10.1016/j.schres.2014.08.021;

Vincenzi B, Borba CP, Gray DA, Copeland PM, Wang X, Fan X, Aragam GG, Henderson DC. An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics. Ann Clin Psychiatry. 2013 May; 25(2):141-8.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 23638445

Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30.View Related Profiles.

Henderson, David
Copeland, Paul

PMID: 23422397; PMCID: PMC5366038; DOI: 10.1097/JCP.0b013e31828701d0;

Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5.View Related Profiles.

Henderson, David
Copeland, Paul

PMID: 23434504; PMCID: PMC3622829; DOI: 10.1016/j.schres.2013.01.034;

Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 22943577; PMCID: PMC4327765; DOI: 10.1111/acps.12009;

Showing 10 of 43 results. Show More

Borba CP, Fan X, Copeland PM, Paiva A, Freudenreich O, Henderson DC. Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. J Clin Psychopharmacol. 2011 Oct; 31(5):653-8.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 21869685; PMCID: PMC3725551; DOI: 10.1097/JCP.0b013e31822bb573;

Henderson DC, Freudenreich O, Borba CP, Wang X, Copeland PM, Macklin E, Fan X, Cather C, Goff DC. Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):53-6.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 21565464; DOI: 10.1016/j.schres.2011.04.009;

Fan X, Copeland PM, Liu EY, Chiang E, Freudenreich O, Goff DC, Henderson DC. No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia. J Clin Psychopharmacol. 2011 Apr; 31(2):231-4.View Related Profiles.

Henderson, David
Freudenreich, Oliver
Copeland, Paul

PMID: 21346605; DOI: 10.1097/JCP.0b013e31820ebd0e;

Henderson DC, Sharma B, Fan X, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. Ann Clin Psychiatry. 2010 Feb; 22(1):33-42.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 20196981

Cole A, Nathan DM, Savaria-Porter E, Copeland P, Turchin A, Brunt M, Zusman R, Barrett JA, Wexler D, Case E, McMahon GT, Mort E. An algorithm for the care of type 2 diabetes. Crit Pathw Cardiol. 2009 Dec; 8(4):156-65. PMID: 19952550

Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract. 2009 Jul; 15(4):251-61.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 19625881; PMCID: PMC2918660; DOI: 10.1097/01.pra.0000358312.99233.ef;

Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. J Clin Psychopharmacol. 2009 Apr; 29(2):165-9.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 19512978; PMCID: PMC4311767; DOI: 10.1097/JCP.0b013e31819a8dbe;

Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Forstbauer SI, Miley K, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia. Hum Psychopharmacol. 2009 Apr; 24(3):225-32.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 19283774; PMCID: PMC4327763; DOI: 10.1002/hup.1012;

Miller JC, Blake MA, Boland GW, Copeland PM, Thrall JH, Lee SI. Adrenal masses. J Am Coll Radiol. 2009 Mar; 6(3):206-11. PMID: 19248999

Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Boxill R, Freudenreich O, Cather C, Eden Evins A, Goff DC. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. Acta Psychiatr Scand. 2009 Jun; 119(6):457-65.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 19183127; PMCID: PMC4296018; DOI: 10.1111/j.1600-0447.2008.01325.x;

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry. 2007 Apr; 68(4):533-41.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 17474808

Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatr Scand. 2007 Feb; 115(2):101-5.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 17244173

Copeland PM. How successful are commercial weight-loss programs? Nat Clin Pract Endocrinol Metab. 2006 Dec; 2(12):658-9. PMID: 17143308

Fan X, Anderson EJ, Copeland PM, Borba CP, Nguyen DD, Freudenreich O, Goff DC, Henderson DC. Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients. Biol Psychiatry. 2006 Dec 15; 60(12):1372-7.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 16920075

Slattery JM, Blake MA, Kalra MK, Misdraji J, Sweeney AT, Copeland PM, Mueller PR, Boland GW. Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol. 2006 Jul; 187(1):W21-4.View Related Profiles.

Sweeney, Ann
Copeland, Paul

PMID: 16794135

Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psychiatry. 2006 May; 67(5):789-97.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 16841629

Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Eden Evins A, Freudenreich O, Baer L, Goff DC. Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb; 113(2):121-5.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 16423163

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry. 2005 Sep; 66(9):1116-21.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 16187768

Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. Am J Psychiatry. 2005 May; 162(5):954-62.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 15863798

Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005 Feb; 66(2):183-94; quiz 147, 273-4.View Related Profiles.

Henderson, David
Duckworth, Ken
Copeland, Paul

PMID: 15705003

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry. 2005 Jan; 62(1):19-28.View Related Profiles.

Borba, Christina
Henderson, David
Copeland, Paul

PMID: 15630069; DOI: 10.1001/archpsyc.62.1.19;

Copeland PM. Management of the clinically inapparent adrenal mass. Ann Intern Med. 2004 Mar 02; 140(5):401; author reply 401-2. PMID: 14996684

Copeland PM. Adrenal incidentaloma. Curr Ther Endocrinol Metab. 1997; 6:189-94. PMID: 9174735

Copeland PM. Two cases of therapeutic failure associated with levothyroxine brand interchange. Ann Pharmacother. 1995 May; 29(5):482-5. PMID: 7655130

Copeland PM, Sacks NR, Herzog DB. Longitudinal follow-up of amenorrhea in eating disorders. Psychosom Med. 1995 Mar-Apr; 57(2):121-6. PMID: 7792370

Fava M, Copeland PM, Schweiger U, Herzog DB. Neurochemical abnormalities of anorexia nervosa and bulimia nervosa. Am J Psychiatry. 1989 Aug; 146(8):963-71. PMID: 2568763

Copeland PM. Diuretic abuse and central pontine myelinolysis. Psychother Psychosom. 1989; 52(1-3):101-5. PMID: 2486385

Herzog DB, Copeland PM. Bulimia nervosa--psyche and satiety. N Engl J Med. 1988 Sep 15; 319(11):716-8. PMID: 3412390

Copeland PM, Herzog DB, Carr DB, Klibanski A, MacLaughlin RA, Martin JB. Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal women. Psychoneuroendocrinology. 1988; 13(3):273-8. PMID: 3406324

Copeland PM, Herzog DB. Hypoglycemia and death in anorexia nervosa. Psychother Psychosom. 1987; 48(1-4):146-50. PMID: 3505707

Copeland PM, Herzog DB. Non-bulimia: food regurgitation in a patient with self-diagnosed bulimia. J Clin Psychiatry. 1986 Jun; 47(6):317-8. PMID: 3086293

Copeland PM. The incidentally discovered adrenal mass. Ann Surg. 1984 Jan; 199(1):116-22. PMID: 6691725

Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med. 1983 Jun; 98(6):940-5. PMID: 6344711

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 43 publications over 23 distinct years, with a maximum of 6 publications in 2009

Bar chart showing 43 publications over 23 distinct years, with a maximum of 6 publications in 2009

Year	Publications
1983	1
1984	1
1986	1
1987	1
1988	2
1989	2
1995	2
1997	1
2004	1
2005	4
2006	5
2007	2
2009	6
2010	1
2011	3
2012	1
2013	3
2014	1
2015	1
2017	1
2018	1
2019	1
2022	1

Contact for Mentoring:

670 Albany St
Boston MA 02118
Google Map

Download vCard

Copeland's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (205) concept(s)

Co-Authors

See all (4) people

Similar People

See all (60) people

Same Department

Search Department